University of Alberta research could pave way for immunocompromised people to safely treat infection.
Using CMCF beamline, researchers from Hospital for Sick Children decode how human antibodies protect us against malaria
New antimicrobial coating could revolutionize cleaning methods
USask researchers have developed a better membrane for dialysis machines that could lead to safer treatment, improved quality of life for patients with kidney failure.
Researchers from the University of British Columbia (UBC) have identified a new protein that helps an oral bacterium thrive in other locations around the body.
Scientists from the University of Guelph have used the Canadian Light Source (CLS) at the University of Saskatchewan to better understand how several infectious bacteria, including E. coli., build a protective sugar-based barrier that helps cloak their cells.
Researchers from McGill University have made an exciting discovery about specific proteins involved in the spread of certain cancers.
A research team based in Winnipeg is using the Canadian Light Source (CLS) at the University of Saskatchewan to find new, cutting-edge ways to battle cancer.
Researchers used the CLS to uncover how structures in cannabis flowers are connected to the plant's complex chemistry.
Researchers from the University of Toronto (U of T) are harnessing the power of proteins to stop cancer cells in their tracks.
Researchers from the University of Toronto (U of T) and The Hospital for Sick Children (SickKids) have identified a promising therapeutic target to help treat lung infections in cystic fibrosis (CF) patients.
Application of a discovery that was aided in part by the Canadian Light Source (CLS) at the University of Saskatchewan has advanced to pre-clinical trials and is now the basis of a dynamic new startup.
Osteoporosis takes heavy toll on Canadians in terms of physical suffering and economic burden.
Wilfrid Laurier researchers are exploring how bacteria target weak points in the connective ligaments in your mouth.
Fresh water is a finite resource vulnerable to contamination.
Better understanding of viral protein could lead to more effective COVID drug treatments with fewer side effects
Although the COVID-19 pandemic may feel like it is winding down for many people, there is still much to be learned about the virus that could help us to keep it at bay in the future.
Strokes are the third leading cause of death in Canada and have impacted close to 880,000 Canadians over the age of 20.
Developing therapeutics for COVID-19 should lessen the length and severity of the illness, keeping more people out of the hospital and improving patient outcomes.
New glow-in-the-dark material can track path of drugs through the human body
For the first time, researchers have used synchrotron imaging to study both the size and spread of bullet fragments in big game shot by hunters.
New structural information about an enzyme target in cancer medicine could help the development of next generation inhibitors.
Tiny motors play large roles in our cells and are targets for new therapies.
Using light brighter than the sun to help identify the cause of hip implant failure.
Synchrotron’s “superhuman vision” made it easy to detect markers of brain damage.
About 38 million people globally are living with HIV.
Scientists work to unlock the full potential of biological machines that can have a huge impact on human health.
Using the CLS, McGill researchers have discovered a small molecule that may help combat COVID-19 and could contribute to a new arsenal of treatments slowly making their way to market.
Researchers analyze chemicals that present health concerns as materials degrade.
Scientists are looking to harness the immune system to fight cancer.
McGill University researchers used the CLS to advance a novel method for growing synthetic bone tissue.
Dr. Kendra Furber uses Mid-IR to focus in on specialized brain cells
A. baumannii is a WHO-recognized critical priority pathogen for research, due to antibiotic resistance
One in every ten Canadians has kidney disease, according to the Kidney Foundation.
Heart valve calcification is one of the leading causes of death in Canada.
Pain relief is a critical issue in medicine, but effective pain management is often overlooked.
Scientists are designing better versions of the drugs used to fight antimicrobial-resistant germs like the deadly hospital-acquired superbug MRSA.
Researchers used the CLS to identify a potential bone health therapy.
Important molecular insights for designing improved cancer therapies.
Filtering out pollutants from indoor air is very important for the health of Canadians - as we spend up to 90% of our time indoors.
Researchers with USask Engineering were able to view an industrial milk-filtering #membrane in a way not seen before using our BMIT beamline
Researchers from the University of Toronto have developed antibodies that can neutralize COVID-19.
Using the CLS, researchers have isolated some promising inhibitors that could be used to treat COVID-19 infections.
Cradle-to-grave product development of successful detergent for athletic use.
Determination of the chemical differences between inorganic salt-based nutritional supplements and amino acid chelate products.
Researchers from McGill University used the CLS to determine the physical structure of largest complex ever measured using the CMCF beamline.
A team of international collaborators has been researching a promising new therapeutic for the treatment of strokes and other brain injuries.
Over 100,000 Canadians are living with Parkinson’s disease. McGill researchers are using the Canadian Light Source to help search for potential drug targets for the disease.
Dr. Jake Pushie is using the CLS and VIDO to study the virus that causes COVID-19 and its effects on blood vessels.
Researchers report new insights into how a class of antibiotics commonly used in both medicine and agriculture are rendered useless by resistant germs.
University of Guelph scientists fight antibiotic resistance by using our synchrotron to study scab disease in potatoes.
University of Saskatchewan scientists have designed an air sanitizing device that could help protect us from airborne pathogens like the ones that cause COVID-19 and the common flu.
Dr. Dustin King with Simon Fraser University and colleagues are using our CMCF beamlines to get a better understanding of how CO2 could be controlled to improve our immunity.
Dr. Jake Pushie's team at the University of Saskatchewan is examining risk factors for bleeding in the brain after stroke.
Ecologik, a Saskatoon-based company, used our CMCF beamline to analyze their dishwasher detergent to ensure there were no unknown contaminants in their product.
McGill researchers used the CLS to get one step closer to understanding the origins of arterial calcification, a process that contributes to heart disease.
By deepening our understanding of how Tuberculosis bacteria feed themselves, University of Guelph researchers have identified a potential target for drug treatment.
Researchers are working to better understand how decontamination procedures might affect the structure and potential reuse of N95 masks.
A team of researchers from the CLS and Memorial University set out to determine whether bromine could be found in household dust.
Streptavidin and biotin form a strong bond invaluable for many biotechnological applications. Researchers have taken a new approach to improve these widely used biotechnology tools.
A University of Nevada researcher is using our Mid-IR beamline to study how nucleic acids get damaged under X-ray irradiation.
Researchers from the CLS and Université Laval are trying to create a device that would make healthcare testing more efficient
Are those relying on private well water potentially at greater risk? Manganese isn’t considered a major water contaminant in America, but a new study is taking a closer look at whether it should be.
University of Calgary researchers are developing therapeutics for COVID-19.
Dr. Jiang Yin is using the CLS to find new therapies that will help treat COVID-19.
A new insight into cell signals that control cancer growth and migration could help in the search for effective anti-cancer drugs, according to McGill University researchers who used the CLS.
Western University and Shanghai Institute of Ceramics researchers used the CLS to explore a promising drug carrier that could be used to deliver cancer treatments and therapeutics for severe injuries.
As the search continues for new antibiotics to treat drug-resistant infections, researchers used the CLS to try to weaken the ability of bacteria to develop resistance in the first place.
Researchers used the CLS to discover how to create stronger dental fillings. This is great news for the 96% of Canadians who will have to contend with at least one cavity during their adult lives.
An innovative radiation treatment that could one day be a valuable addition to conventional radiation therapy for inoperable brain and spinal tumors is a step closer, thanks to new research led by researchers at the CLS.
Researchers used the CLS to identify a previously unrecognized family of enzymes that put us at risk for deadly diseases.
Researchers from McGill University and Yale University used the CLS to make a discovery that could help design future therapeutic drugs.
Scientists from McGill University used the CLS to uncover that different minerals block heart valves in men versus women. This discovery could impact how heart disease is diagnosed and treated for the different sexes.
A discovery by an international group of scientists challenges known research on diabetes and may open the door to new therapeutic approaches for the disease that affects nearly 500 million people globally.
Researchers use Canadian Light Source to advance the quest for an easy, inexpensive and effective filtration system that can be used in underdeveloped and remote areas of the world.
CLS helps biopharmaceutical company Merck to make a vaccine breakthrough for Respiratory Syncytial Virus (RSV), a virus that is one of the leading causes of hospitalization in babies.
McGill researchers use the CLS to analyze a new class of compounds that could help develop novel therapies for age-related cancers.
Scientists used the CLS to solve the structure of an enzyme that could help burn victims and prevent deaths from different kinds of infections.
Researchers have made great strides in understanding the functioning of enzymes that play and integral role in the production of antibiotics and other therapeutics.
A team of researchers from the University of Calgary has uncovered new information about a class of plant enzymes that could have implications for the pharmaceutical industry.
An international research team used the CLS to help determine the atomic structure of a protein kinase in parasites that cause malaria, which could help create a new generation of anti-malarial drugs.
Researchers used the CLS to study proteins that a pathogen uses to break down sugar chains (glycans) present in human tissue during infections. This could lead to new treatments approaches for the bacterium.
Scientists from Quebec take an important step towards finding a potential cure for the disease that causes some strokes and heart attacks.
Researchers from the University of British Columbia used the Canadian Light Source to study a protein that could help prevent colorectal cancer and stillbirths.
Leukemia affects over 6,000 Canadians per year. A team of researchers used the Canadian Light Source to discover a new way to kill leukemia cancer cells.
Researchers from the Universities of Guelph and Alberta used the CLS to identify a possible target in the prevention and treatment of bacterial infections.
Using advanced techniques at the CLS, scientists have created three-dimensional images of the complex interior anatomy of the human ear, which is key to improving the design of hearing implants.
Researchers from University of British Columbia have made a breakthrough in their technique for converting A and B type blood into universal O, the type that is most needed by blood services.
Guided by “blueprints” produced at the CLS, scientists made structural changes to an antibody that is now showing a lot of potential for reducing cancer tumours.
Scientists have shown that heart arrhythmia can be acquired by people who are stressed out even if they have no genetic predisposition. This condition serves as a warning signal for atrial fibrillation and potential heart failure. The good news is that these researchers may have also discovered a potential therapy.
There is a potential therapy on the horizon for people suffering from treatment-resistant depression thanks to a small biotech firm’s discovery of a molecule linked to cell function in the brain.
A University of Saskatchewan medical research team has made a groundbreaking finding with potential to lead to more effective treatments for cystic fibrosis (CF).
Arrhythmia mutations in key proteins that oversees cellular functions crucial to health and survival
Researchers used the CLS to help understand the protein responsible for regulating heartbeats.
Using the CLS, SickKids scientists have taken an important step forward on the path to finding effective biomedical interventions to halt the spread of malaria.
Researchers from McMaster University have found a new way to look for Alzheimer’s treatments, a disease that affects over 747,000 Canadians.
Synchrotron scientists conclude lead poisoning did not play a pivotal role in the deaths of crew members on the Franklin Expedition.
University of Saskatchewan researchers have looked at how we can use 3D printing to help damaged nervous systems to regrow.